DOCSLIB.ORG

Recent Advances in the Synthesis of Hydantoins: the State of the Art of a Valuable Scaffold Laure Konnert, Frédéric Lamaty, Jean Martinez, Evelina Colacino

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Recent Advances in the Synthesis of Hydantoins: the State of the Art of a Valuable Scaffold Laure Konnert, Frédéric Lamaty, Jean Martinez, Evelina Colacino Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold Laure Konnert, Frédéric Lamaty, Jean Martinez, Evelina Colacino To cite this version: Laure Konnert, Frédéric Lamaty, Jean Martinez, Evelina Colacino. Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. Chemical Reviews, American Chemical Society, 2017, 117 (23), pp.13757-13809. 10.1021/acs.chemrev.7b00067. hal-02385289 HAL Id: hal-02385289 https://hal.archives-ouvertes.fr/hal-02385289 Submitted on 5 Mar 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Review Cite This: Chem. Rev. 2017, 117, 13757−13809 pubs.acs.org/CR Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold Laure Konnert,* Fredérić Lamaty, Jean Martinez, and Evelina Colacino* Universitéde Montpellier, Institut des Biomoleculeś Max Mousseron UMR 5247 CNRS − Universiteś Montpellier - ENSCM, Place E. Bataillon, Campus Triolet, cc 1703, 34095 Montpellier, France ABSTRACT: The review highlights the hydantoin syntheses presented from the point of view of the preparation methods. Novel synthetic routes to various hydantoin structures, the advances brought to the classical methods in the aim of producing more sustainable and environmentally friendly procedures for the preparation of these biomolecules, and a critical comparison of the different synthetic approaches developed in the last twelve years are also described. The review is composed of 95 schemes, 8 figures and 528 references for the last 12 years and includes the description of the hydantoin-based marketed drugs and clinical candidates. CONTENTS 5.4.4. Use of Benzotriazole Carbonyl Deriva- tives 13769 1. Introduction 13758 5.4.5. Activation by Formation of Carbamates 13769 2. Hydantoins as Clinical Candidates and Marketed 5.4.6. From Urea and Other Activation Meth- Drugs 13758 ods 13769 2.1. Clinical Candidates 13758 6. 1,3,5- and 1,3,5,5-Substituted Hydantoins 13769 2.1.1. BMS-587101 13758 6.1. Substitution of the Hydantoin Core 13769 2.1.2. GLGP-0492 13760 6.2. Use of Isocyanates 13770 2.2. Marketed Drugs 13760 6.3. Use of Urea Derivatives 13771 2.2.1. Phenytoin and Fosphenytoin 13760 6.4. Activation with Carbonyl Donors 13771 2.2.2. Ethotoin 13760 6.5. Miscellaneous 13772 2.2.3. Nilutamide 13760 7. Alkylidene Hydantoins 13773 2.2.4. Nitrofurantoin 13760 7.1. Non-substituted 5-Alkyl/Arylidene Hydan- 2.2.5. Dantrolene 13760 toins 13773 3. 5- and 5,5-Disubstituted Hydantoins 13760 − 7.2. 1-Substituted 5-Alkyl/Arylidene Hydantoins 13773 3.1. Bucherer Bergs Reaction 13761 7.3. 3-Substituted 5-Alkyl/Arylidene Hydantoins 13774 3.2. Use of Isocyanates and Formation of Urea 7.4. 1,3,5-Alkyl/Arylidene Hydantoins 13774 Derivatives 13761 8. Spirohydantoins 13775 3.3. Biltz-Type Synthesis, Preparation of Pheny- 8.1. 5,5-Spirohydantoins 13775 toin Derivatives 13762 8.1.1. The Bucherer−Bergs Reaction 13775 3.4. Substitution at Position C-5 13762 8.1.2. Reaction with (Iso)cyanates and Urea 3.5. Metal-Catalyzed Procedures 13762 Derivatives 13775 4. 1- and 1,5-Disubstituted Hydantoins 13763 8.2. 1-Substituted or 3-Substituted 5-Spirohydan- 4.1. Use of Isocyanates and Ureas 13763 toins 13775 4.2. Biltz Synthesis 13763 N 8.3. 1,3-Disubstituted 5-Spirohydantoins 13776 4.3. Alkylation/Acylation at -1 Position 13764 8.3.1. From Methylene Hydantoins 13776 4.4. Miscellaneous 13765 8.3.2. From Diverse Substrates 13776 4.5. Hydantoins Derived from Guanosine and 9. Fused Hydantoins 13778 Analogues 13765 9.1. 1,5-Bicyclic Hydantoins 13778 5. 3- and 3,5-Disubstituted Hydantoins 13766 N 9.2. Polycyclic Fused 1,3,5-Trisubstituted Hydan- 5.1. Alkylation/Acylation at the -3 Position 13766 toins 13779 5.2. Use of Isocyanates 13766 9.2.1. Tetrahydroisoquinoline Hydantoins 13779 5.3. Miscellaneous 13767 9.2.2. Tetrahydro-β-carboline Hydantoins 13780 5.4. 3-Substituted Hydantoins from Amino Acids 13767 9.2.3. Miscellaneous 13780 5.4.1. Use of Isocyanates 13767 10. Aminohydantoins 13780 5.4.2. Use of 1,1-Carbonyldiimidazole (CDI) 13768 5.4.3. Use of (Tri)phosgene 13769 Received: January 30, 2017 Published: June 23, 2017 © 2017 American Chemical Society 13757 DOI: 10.1021/acs.chemrev.7b00067 Chem. Rev. 2017, 117, 13757−13809 Chemical Reviews Review 10.1. 1-Aminohydantoins 13780 compounds are highlighted (mono-, di-, or trisubstituted 10.2. 3-Aminohydantoins 13782 hydantoins on the C-5, N-1/N-3 positions, fused and polycyclic 10.3. 5-Aminohydantoins 13783 systems, spiro-, alkylidene or amino- hydantoins), including their 11. Hydantoins as Ligands in Organometallic Com- use as organometallic ligands (Figure 1). One of the advantages plexes 13784 12. Asymmetric Synthesis of Hydantoins 13785 12.1. 5,5-Disubstituted Hydantoins 13785 12.1.1. Bucherer−Bergs Synthesis 13785 12.1.2. Other Procedures 13785 12.2. 1,5-Disubstituted Hydantoins 13785 12.3. 3,5-Substituted Hydantoins 13785 12.3.1. Alkylation of Position C-5 13785 12.3.2. Miscellaneous 13785 12.4. 1,3,5-Trisubstituted Hydantoins 13786 12.4.1. Use of Isocyanates 13786 12.4.2. Synthesis of BIRT-377, Generation of a Chiral Quaternary Center 13787 12.4.3. Use of Urea Derivatives 13788 12.5. 5,5-Spirohydantoins 13789 12.5.1. Bucherer−Bergs Reaction 13789 12.5.2. Reaction with Isocyanates and Urea Derivatives 13789 12.6. 1,3-Disubstituted Spirohydantoins 13789 12.6.1. From Methylene Hydantoins 13789 12.6.2. From Other Substrates 13789 12.7. Fused Hydantoins 13791 12.7.1. 1,5-Bicyclic Hydantoins 13791 12.7.2. Polycyclic Fused 1,3,5-Trisubstituted Hydantoins 13792 13. Preparation of Amino Acids from Hydantoins 13792 13.1. Chemical Hydrolysis 13792 Figure 1. Hydantoin core and the classes of hydantoins. 13.2. Enzymatic Hydrolysis of Hydantoins 13793 14. Conclusions 13794 ff Author Information 13794 of organizing the review from the point of view of the sca old Corresponding Authors 13794 (and not considering the general method to access it) is the possibility to overview at a glance all of the available procedures ORCID 13794 fi Notes 13794 to access a speci c family of compounds. This approach is very valuable not only for synthetic chemists Biographies 13794 fi References 13794 but also for a broader readership in the eld of medicinal Note Added after ASAP Publication 13809 chemistry, where target oriented syntheses is a must. The preparation of thiohydantoins will not be treated, being usually obtained similarly to hydantoins, but in the presence of thio- 1. INTRODUCTION based reactants, or by transformation of the hydantoin scaffold by common thionation reactions (e.g., Lawesson’s method). Over the past decade, the synthetic and pharmaceutical interest Reviews on their preparation were already reported.9,10 More- for imidazolidine-2,4-diones, or hydantoins, has not faded and over, the detailed description of the diverse biological activities has given rise to more than 3000 publications and patents in displayed by hydantoin scaffolds is out of the scope of the review, methodological and medicinal chemistry. Several reviews have − and it would deserve a separate submission. focused on the synthesis of these five-membered heterocycles,1 3 referencing their preparation methods from the main, historical 2. HYDANTOINS AS CLINICAL CANDIDATES AND 4 5 6 ones such as the Read, Bucherer−Bergs, or Biltz syntheses to MARKETED DRUGS more modern ones, such as multicomponent reactions (MCRs), Many biological properties have been attributed to compounds which enabled libraries of hydantoinic compounds to be 7,8 containing a hydantoin moiety, as illustrated throughout the obtained through simple routes. Since Meusel and Gütschow’s 3 following sections of this review. Several of them have last review in 2004, novel synthetic routes to various hydantoin demonstrated strong bioactivity and thus have been led through structures have been explored, as well as advances brought to the clinical trials,11,12 and some of them have been commercialized as classical methods in the aim of producing more sustainable and pharmaceuticals.13 In this section a short overview of hydantoin- environmental-friendly procedures for the preparation of these containing clinical candidates (from 2004 to 2016) and marketed biomolecules. This paper is updating the progress in the drugs is given, the structures of which are depicted in Figures 3 chemistry of hydantoins and references the publications from and 4. 2004 to May 2016. It is organized in a different perspective than the previous report from 2004: hydantoins are grouped 2.1. Clinical Candidates according to the substitution pattern on the principal backbone 2.1.1. BMS-587101. BMS587101 is a spirocyclic hydantoin and the synthetic strategies for the preparation of each family of which was developed by Bristol-Myers Squibb and showed 13758 DOI: 10.1021/acs.chemrev.7b00067 Chem. Rev. 2017, 117, 13757−13809 Chemical Reviews Review Figure 2. X-ray crystal structures of BMS-587101 (left) and BMS-688521 (right) bound to the I-Domain of LFA-1 (image reproduced with permission from ref 15. Copyright 2014 American Chemical Society). Figure 3. Hydantoin clinical candidates. Figure 4. Hydantoin marketed drugs. biological activity as a leukocyte function-associated antigen-1 688521,15 showing a 4- to 8-fold improvement in human in (LFA-1) antagonist.
Load more

Recommended publications
  • United States July 2016 2 Table of Contents
    Deuterium Labelled Compounds United States July 2016 2 Table of Contents International Distributors 3 Corporate Overview 4 General Information 5 Pricing and Payment 5 Quotations 5 Custom Synthesis 5 Shipping 5 Quality Control 6 Quotations 6 Custom Synthesis 6 Shipping 6 Quality Control 6 Chemical Abstract Service Numbers 6 Handling Hazardous Compounds 6 Our Products are Not Intended for Use in Humans 7 Limited Warranty 7 Packaging Information 7 Alphabetical Listings 8 Stock Clearance 236 Products by Category 242 n-Alkanes 243 α-Amino Acids, N-Acyl α-Amino Acids, N-t-BOC Protected α-Amino Acid 243 and N-FMOC Protected α-Amino Acids Buffers and Reagents for NMR Studies 245 Detergents 245 Environmental Standards 246 Fatty Acids and Fatty Acid Esters 249 Flavours and Fragrances 250 Gases 253 Medical Research Products 254 Nucleic Acid Bases and Nucleosides 255 Pesticides and Pesticide Metabolites 256 Pharmaceutical Standards 257 Polyaromatic Hydrocarbons (PAHs), Alkyl-PAHs, Amino-PAHs, 260 Hydroxy-PAHs and Nitro-PAHs Polychlorinated Biphenyls (PCBs) 260 Spin Labels 261 Steroids 261 3 International Distributors C Beijng Zhenxiang H EQ Laboratories GmbH Australia K Technology Company Graf-von-Seyssel-Str. 10 Rm. 15A01, Changyin Bld. 86199 Augsburg Austria H No. 88, YongDingLu Rd. Germany Beijing 100039 Tel.: (49) 821 71058246 Belgium J China Fax: (49) 821 71058247 Tel.: (86) 10-58896805 [email protected] China C Fax: (86) 10-58896158 www.eqlabs.de Czech Republic H [email protected] Germany, Austria, China Czech Republic, Greece, Denmark I Hungary,
    [Show full text]
  • Campro Catalog Stable Isotope
    Introduction & Welcome Dear Valued Customer, We are pleased to present to you our Stable Isotopes Catalog which contains more than three thousand (3000) high quality labeled compounds. You will find new additions that are beneficial for your research. Campro Scientific is proud to work together with Isotec, Inc. for the distribution and marketing of their stable isotopes. We have been working with Isotec for more than twenty years and know that their products meet the highest standard. Campro Scientific was founded in 1981 and we provide services to some of the most prestigious universities, research institutes and laboratories throughout Europe. We are a research-oriented company specialized in supporting the requirements of the scientific community. We are the exclusive distributor of some of the world’s leading producers of research chemicals, radioisotopes, stable isotopes and environmental standards. We understand the requirements of our customers, and work every day to fulfill them. In working with us you are guaranteed to receive: - Excellent customer service - High quality products - Dependable service - Efficient distribution The highly educated staff at Campro’s headquarters and sales office is ready to assist you with your questions and product requirements. Feel free to call us at any time. Sincerely, Dr. Ahmad Rajabi General Manager 180/280 = unlabeled 185/285 = 15N labeled 181/281 = double labeled (13C+15N, 13C+D, 15N+18O etc.) 186/286 = 12C labeled 182/282 = d labeled 187/287 = 17O labeled 183/283 = 13C labeleld 188/288 = 18O labeled 184/284 = 16O labeled, 14N labeled 189/289 = Noble Gases Table of Contents Ordering Information.................................................................................................. page 4 - 5 Packaging Information ..............................................................................................
    [Show full text]
  • Hypothalamic Principles Necessary for the Release of Ovulating Hormone from the Adenohypophysis
    EFFECT OF AMINOGLUTETHIMIDE ON REPRODUCTIVE PROCESSES IN FEMALE RATS W. J. EVERSOLE and D. J. THOMPSON Department of Life Sciences, Indiana State University, Terre Haute, Indiana 47809, U.S.A. (Received "òlst January 1974) Summary. Adult female rats injected subcutaneously with 100 mg aminoglutethimide phosphate (AGP)/kg/day for 4 weeks failed to become pregnant when placed in cohabitation with males during the last 2 weeks of the injection period. Lower doses depressed the fertility rate and reduced the litter size: the average litter size of three of eleven rats given 50 mg/kg/day was 4\m=.\7 young and of four of eleven rats given 25 mg was 7\m=.\0 young. Twenty-nine controls averaged 10\m=.\1/litter. Doses of 100 mg AGP/kg/day stopped vaginal cycling, prevented ovulation in adults, and delayed dissolution of the vaginal membrane in pubertal rats. Histological studies of the ovaries from rats with initial ages of 17 or 21 days which were injected with 25 to 100 mg AGP/kg/day for 2 weeks showed an increase in the number and size of vesicular follicles. Treatment of 27-day-old rats with 25 mg/kg/day for 2 weeks reduced the number of CL and three of four rats given 50 mg had ovaries lacking such bodies; all control ovaries in this group contained CL. These findings are taken as evidence that AGP inhibits ovulation but does not prevent follicular maturation. INTRODUCTION Many pharmacological compounds originally developed as anaesthetics, tranquillizers and anticonvulsants modify endocrine structures and functions (see Gaunt, Chart & Renzi, 1965).
    [Show full text]
  • Basic and Clinical Pharmacology 12/E
    Dr. Murtadha Alshareifi e-Library SECTION V DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM CHAPTER Introduction to the 21 Pharmacology of CNS Drugs Roger A. Nicoll, MD Drugs acting in the central nervous system (CNS) were among the are extremely useful in such studies. The Box, Natural Toxins: first to be discovered by primitive humans and are still the most Tools for Characterizing Ion Channels, describes a few of these widely used group of pharmacologic agents. In addition to their substances. use in therapy, many drugs acting on the CNS are used without Third, unraveling the actions of drugs with known clinical prescription to increase the sense of well-being. efficacy has led to some of the most fruitful hypotheses regarding The mechanisms by which various drugs act in the CNS have the mechanisms of disease. For example, information about the not always been clearly understood. In recent decades, however, action of antipsychotic drugs on dopamine receptors has provided dramatic advances have been made in the methodology of CNS the basis for important hypotheses regarding the pathophysiology pharmacology. It is now possible to study the action of a drug on of schizophrenia. Studies of the effects of a variety of agonists and individual cells and even single ion channels within synapses. The antagonists on γ-aminobutyric acid (GABA) receptors have information obtained from such studies is the basis for several resulted in new concepts pertaining to the pathophysiology of major developments in studies of the CNS. several diseases, including anxiety and epilepsy. First, it is clear that nearly all drugs with CNS effects act on This chapter provides an introduction to the functional orga- specific receptors that modulate synaptic transmission.
    [Show full text]
  • Old Time Chemical Names
    Old Time Chemical Names 1080------------------------------------------------Sodium fluroacetate 2-Propanone-------------------------------------Acetone Absinthe-------------------------------------------Distillate of worm wood Abstinthium--------------------------------------Distillate of worm wood Acarcia gum-------------------------------------Gum arabic Acetaldehyde------------------------------------Acetic aldehyde Acetate of alumina-----------------------------Aluminium acetate Acetate of ammonia---------------------------Ammonium acetate Acetate of amyl---------------------------------Amyl acetate Acetate of baryta-------------------------------Barium acetate Acetate of cobalt-------------------------------Cobalt acetate Acetate of copper------------------------------Copper acetate Acetate of ethyl---------------------------------Ethyl acetate Acetate of iron----------------------------------Iron acetate Acetate of lead----------------------------------Lead acetate Acetate of lime----------------------------------Calcium acetate Acetate of manganese------------------------Manganous acetate Acetate of oxide of ethyl---------------------Ethyl acetate Acetate of potassa-----------------------------Potassium acetate Acetate of potassium--------------------------Potassium acetate Acetate of protoxide of Manganese-------Manganous acetate Acetate of soda---------------------------------Sodium acetate Acetate of zinc----------------------------------Zinc acetate Acetic aid basic bismuth---------------------Bismuth subacetate CH3COOBiO Acetic
    [Show full text]
  • Genetically Modified Baculoviruses for Pest
    INSECT CONTROL BIOLOGICAL AND SYNTHETIC AGENTS This page intentionally left blank INSECT CONTROL BIOLOGICAL AND SYNTHETIC AGENTS EDITED BY LAWRENCE I. GILBERT SARJEET S. GILL Amsterdam • Boston • Heidelberg • London • New York • Oxford Paris • San Diego • San Francisco • Singapore • Sydney • Tokyo Academic Press is an imprint of Elsevier Academic Press, 32 Jamestown Road, London, NW1 7BU, UK 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 525 B Street, Suite 1800, San Diego, CA 92101-4495, USA ª 2010 Elsevier B.V. All rights reserved The chapters first appeared in Comprehensive Molecular Insect Science, edited by Lawrence I. Gilbert, Kostas Iatrou, and Sarjeet S. Gill (Elsevier, B.V. 2005). All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publishers. Permissions may be sought directly from Elsevier’s Rights Department in Oxford, UK: phone (þ44) 1865 843830, fax (þ44) 1865 853333, e-mail [email protected]. Requests may also be completed on-line via the homepage (http://www.elsevier.com/locate/permissions). Library of Congress Cataloging-in-Publication Data Insect control : biological and synthetic agents / editors-in-chief: Lawrence I. Gilbert, Sarjeet S. Gill. – 1st ed. p. cm. Includes bibliographical references and index. ISBN 978-0-12-381449-4 (alk. paper) 1. Insect pests–Control. 2. Insecticides. I. Gilbert, Lawrence I. (Lawrence Irwin), 1929- II. Gill, Sarjeet S. SB931.I42 2010 632’.7–dc22 2010010547 A catalogue record for this book is available from the British Library ISBN 978-0-12-381449-4 Cover Images: (Top Left) Important pest insect targeted by neonicotinoid insecticides: Sweet-potato whitefly, Bemisia tabaci; (Top Right) Control (bottom) and tebufenozide intoxicated by ingestion (top) larvae of the white tussock moth, from Chapter 4; (Bottom) Mode of action of Cry1A toxins, from Addendum A7.
    [Show full text]
  • Formaldehyde Test Kit Utility
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Cutan Ocul Manuscript Author Toxicol. Author Manuscript Author manuscript; available in PMC 2019 June 01. Published in final edited form as: Cutan Ocul Toxicol. 2019 June ; 38(2): 112–117. doi:10.1080/15569527.2018.1471485. Undeclared Formaldehyde Levels in Patient Consumer Products: Formaldehyde Test Kit Utility Jason E. Ham1, Paul Siegel1,*, and Howard Maibach2 1Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA 2Department of Dermatology, School of Medicine, University of California-San Francisco, San Francisco, CA, USA Abstract Formaldehyde allergic contact dermatitis (ACD) may be due to products with free formaldehyde or formaldehyde-releasing agents, however, assessment of formaldehyde levels in such products is infrequently conducted. The present study quantifies total releasable formaldehyde from “in-use” products associated with formaldehyde ACD and tests the utility of commercially available formaldehyde spot test kits. Personal care products from 2 patients with ACD to formaldehyde were initially screened at the clinic for formaldehyde using a formaldehyde spot test kit. Formaldehyde positive products were sent to the laboratory for confirmation by gas chromatography-mass spectrometry. In addition, 4 formaldehyde spot test kits were evaluated for potential utility in a clinical setting. Nine of the 10 formaldehyde spot test kit positive products obtained from formaldehyde allergic patients had formaldehyde with total releasable formaldehyde levels ranging from 5.4 to 269.4 μg/g. Of these, only 2 shampoos tested listed a formaldehyde-releasing agent in the ingredients or product literature. Subsequently, commercially available formaldehyde spot test kits were evaluated in the laboratory for ability to identify formaldehyde in personal care products.
    [Show full text]
  • Transcriptomic Characterization of Bradyrhizobium Diazoefficiens
    International Journal of Molecular Sciences Article Transcriptomic Characterization of Bradyrhizobium diazoefficiens Bacteroids Reveals a Post-Symbiotic, Hemibiotrophic-Like Lifestyle of the Bacteria within Senescing Soybean Nodules Sooyoung Franck 1, Kent N. Strodtman 1 , Jing Qiu 2 and David W. Emerich 1,* 1 Division of Biochemistry, University of Missouri, Columbia, MO 65211, USA; [email protected] (S.F.); [email protected] (K.N.S.) 2 Applied Economics and Statistics, University of Delaware, Newark, DE 19716, USA; [email protected] * Correspondence: [email protected]; Tel: +1-573-882-4252 Received: 8 October 2018; Accepted: 28 November 2018; Published: 7 December 2018 Abstract: The transcriptional activity of Bradyrhizobium diazoefficens isolated from soybean nodules was monitored over the period from symbiosis to late plant nodule senescence. The bacteria retained a near constant level of RNA throughout this period, and the variation in genes demonstrating increased, decreased, and/or patterned transcriptional activity indicates that the bacteria are responding to the changing environment within the nodule as the plant cells progress from an organized cellular structure to an unorganized state of internal decay. The transcriptional variation and persistence of the bacteria suggest that the bacteria are adapting to their environment and acting similar to hemibiotrophs, which survive both as saprophytes on live plant tissues and then as necrophytes on decaying plant tissues. The host plant restrictions of symbiosis make B. diazoefficiens a highly specialized, restricted hemibiotroph. Keywords: bradyrhizobium diazoefficiens; soybean; Glycine max; nitrogen fixation; senescence; transcriptomics; hemibiotroph 1. Introduction Soybean nodules are symbiotic organs that are formed on roots by the complex interaction between soybean plants and rhizobia, nitrogen-fixing bacteria, under nitrogen-limiting conditions.
    [Show full text]
  • Working with Hazardous Chemicals
    A Publication of Reliable Methods for the Preparation of Organic Compounds Working with Hazardous Chemicals The procedures in Organic Syntheses are intended for use only by persons with proper training in experimental organic chemistry. All hazardous materials should be handled using the standard procedures for work with chemicals described in references such as "Prudent Practices in the Laboratory" (The National Academies Press, Washington, D.C., 2011; the full text can be accessed free of charge at http://www.nap.edu/catalog.php?record_id=12654). All chemical waste should be disposed of in accordance with local regulations. For general guidelines for the management of chemical waste, see Chapter 8 of Prudent Practices. In some articles in Organic Syntheses, chemical-specific hazards are highlighted in red “Caution Notes” within a procedure. It is important to recognize that the absence of a caution note does not imply that no significant hazards are associated with the chemicals involved in that procedure. Prior to performing a reaction, a thorough risk assessment should be carried out that includes a review of the potential hazards associated with each chemical and experimental operation on the scale that is planned for the procedure. Guidelines for carrying out a risk assessment and for analyzing the hazards associated with chemicals can be found in Chapter 4 of Prudent Practices. The procedures described in Organic Syntheses are provided as published and are conducted at one's own risk. Organic Syntheses, Inc., its Editors, and its Board of Directors do not warrant or guarantee the safety of individuals using these procedures and hereby disclaim any liability for any injuries or damages claimed to have resulted from or related in any way to the procedures herein.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Colletotrichum Graminicola</Em>
    University of Kentucky UKnowledge Plant Pathology Faculty Publications Plant Pathology 3-8-2016 A Colletotrichum graminicola Mutant Deficient in the Establishment of Biotrophy Reveals Early Transcriptional Events in the Maize Anthracnose Disease Interaction Maria F. Torres University of Kentucky, [email protected] Noushin Ghaffari Texas A&M University Ester A. S. Buiate University of Kentucky, [email protected] Neil Moore University of Kentucky, [email protected] Scott chS wartz Texas A&M University FSeoe nelloxtw pa thige fors aaddndition addal aitutionhorsal works at: https://uknowledge.uky.edu/plantpath_facpub Part of the Bioinformatics Commons, Genomics Commons, Integrative Biology Commons, and Right click to open a feedback form in a new tab to let us know how this document benefits oy u. the Plant Pathology Commons Repository Citation Torres, Maria F.; Ghaffari, Noushin; Buiate, Ester A. S.; Moore, Neil; Schwartz, Scott; Johnson, Charles D.; and Vaillancourt, Lisa J., "A Colletotrichum graminicola Mutant Deficient in the Establishment of Biotrophy Reveals Early Transcriptional Events in the Maize Anthracnose Disease Interaction" (2016). Plant Pathology Faculty Publications. 53. https://uknowledge.uky.edu/plantpath_facpub/53 This Article is brought to you for free and open access by the Plant Pathology at UKnowledge. It has been accepted for inclusion in Plant Pathology Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Authors Maria F. Torres, Noushin Ghaffari, Ester A. S. Buiate, Neil Moore, Scott chS wartz, Charles D. Johnson, and Lisa J. Vaillancourt A Colletotrichum graminicola Mutant Deficient in the Establishment of Biotrophy Reveals Early Transcriptional Events in the Maize Anthracnose Disease Interaction Notes/Citation Information Published in BMC Genomics, v.17, 202, p.
    [Show full text]
  • Application of Multicomponent Reactions in the Total Synthesis of Natural Peptides
    The Free Internet Journal Review for Organic Chemistry Archive for Arkivoc 2019, part i, 0-0 Organic Chemistry to be inserted by editorial office Application of multicomponent reactions in the total synthesis of natural peptides Ghodsi Mohammadi Ziarani,* Razieh Moradi, and Leyla Mahammadkhani Department of Chemistry, Alzahra University, Vanak Square, P.O. Box 1993893973, Tehran, Iran E-mail address: [email protected], [email protected] Received 10-10-2018 Accepted 03-01-2019 Published on line 04-28-2019 Dates to be inserted by editorial office Abstract Multicomponent reactions (MCRs) have been widely applied for the synthesis of biologically active molecules with high complexity and diversity. Nowadays, total synthesis of natural peptides, due to their multifarious application areas, has attracted much attention of organic chemists. MCRs are a powerful and efficient method for the production of natural peptides in a limited number of steps. This review presents an overview on application of multicomponent reactions as a key step in the synthesis of natural peptides. Keywords: Natural peptides, natural products, multicomponent reactions, biological activity DOI: https://doi.org/10.24820/ark.5550190.p010.779 Page 1 ©ARKAT USA, Inc Arkivoc 2019, i, 0-0 Mohammadi-Ziarani, G. et al. Table of Contents 1. Introduction 2. Application of Multicomponent Reactions in the Total Synthesis of Natural Peptides 2.1. Syntheses based on the Ugi reaction 2.2. Syntheses based on the Passerini reaction 2.3. Miscellaneous reactions 3. Conclusions
    [Show full text]